These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Idiotypes and autoimmunity. Male DK Clin Exp Immunol; 1986 Jul; 65(1):1-9. PubMed ID: 3098469 [No Abstract] [Full Text] [Related]
3. Human monoclonal multiple-organ-reactive autoantibodies distinguished by mouse monoclonal anti-idiotypic antibodies: expression of idiotopes in humans with and without autoimmune diseases. Uchigata Y; Prabhakar BS; Salata KF; Ginsberg-Fellner F; Notkins AL J Immunol; 1987 Jun; 138(12):4218-21. PubMed ID: 3495582 [TBL] [Abstract][Full Text] [Related]
4. Idiotypes and anti-idiotypes in experimental autoimmune myasthenia gravis. Souroujon MC; Fuchs S Ann N Y Acad Sci; 1986; 475():81-93. PubMed ID: 3491567 [No Abstract] [Full Text] [Related]
6. Immunologic and genetic factors in autoimmune diseases. Shoenfeld Y; Schwartz RS N Engl J Med; 1984 Oct; 311(16):1019-29. PubMed ID: 6384779 [No Abstract] [Full Text] [Related]
7. Rational design of peptide vaccines for autoimmune disease: harnessing molecular recognition to fix a broken network. Weathington NM; Blalock JE Expert Rev Vaccines; 2003 Feb; 2(1):61-73. PubMed ID: 12901598 [TBL] [Abstract][Full Text] [Related]
8. A possible cause of myasthenia gravis: idiotypic networks involving bacterial antigens. Dwyer DS; Vakil M; Bradley RJ; Oh SJ; Kearney JF Ann N Y Acad Sci; 1987; 505():461-71. PubMed ID: 2446558 [No Abstract] [Full Text] [Related]
9. Idiotype network and its relevance to autoimmune diseases. Functional considerations. Zanetti M Concepts Immunopathol; 1986; 3():253-84. PubMed ID: 3036360 [No Abstract] [Full Text] [Related]
11. Anti-idiotypic immunity: considerations on the immunology of kidney diseases. Zanetti M Contrib Nephrol; 1989; 69():9-17; discussion 37-8. PubMed ID: 2661146 [No Abstract] [Full Text] [Related]
12. The auto-anti-idiotypic route to antireceptor antibodies. Erlanger BF; Cleveland WL; Wassermann NH; Ku HH; Hill BL; Wan KK; Sarangarajan R; Penn AS Ann N Y Acad Sci; 1986; 475():219-26. PubMed ID: 3491562 [No Abstract] [Full Text] [Related]
13. [Autoimmune syndromes in human clinical cases]. Seligmann M; Cannat A Ann Inst Pasteur (Paris); 1970 Apr; 118(4):485-512. PubMed ID: 4912022 [No Abstract] [Full Text] [Related]
14. Possible strategies for the treatment of myasthenia gravis and other autoimmune diseases. Nossal GJ Ann N Y Acad Sci; 1987; 505():610-8. PubMed ID: 3500669 [No Abstract] [Full Text] [Related]
15. Autoantibodies: friend or foe? Sharp GC; Irvin WS Am J Med Sci; 1970 Jun; 259(6):365-72. PubMed ID: 4912273 [No Abstract] [Full Text] [Related]
16. The idiotype-antiidiotype network in human autoimmunity. Abdou NI J Clin Immunol; 1985 Nov; 5(6):365-9. PubMed ID: 3003147 [No Abstract] [Full Text] [Related]
17. Recent advances in the pathogenesis of systemic lupus erythematosus. Jacob L; Viard JP; Louvard D; Bach JF Adv Nephrol Necker Hosp; 1990; 19():237-55. PubMed ID: 2105581 [No Abstract] [Full Text] [Related]
18. Anti-idiotypic antibodies and autoantibodies. Zanetti M Ann N Y Acad Sci; 1983; 418():363-78. PubMed ID: 6608905 [TBL] [Abstract][Full Text] [Related]
19. Connection between autoimmunity to cartilage type II collagen and rheumatoid factor production. Holmdahl R; Tarkowski A; Nordling C; Rubin K; Klareskog L Monogr Allergy; 1987; 22():71-80. PubMed ID: 3437904 [No Abstract] [Full Text] [Related]
20. Autoantiidiotypic antibodies in myasthenia gravis. Lefvert AK; Holm G; Pirskanen R Ann N Y Acad Sci; 1987; 505():133-54. PubMed ID: 3500664 [No Abstract] [Full Text] [Related] [Next] [New Search]